-
公开(公告)号:US6063799A
公开(公告)日:2000-05-16
申请号:US29205
申请日:1998-02-25
IPC分类号: A61K31/426 , C07D277/14 , A61K31/425 , C07D277/04
CPC分类号: A61K31/426 , C07D277/14
摘要: The instant invention provides novel crystalline Form II of (.+-.)-5-{[3,5-bis(1,1dimethylethyl)-4-hydroxyphenyl]methyl}-4-thiazolidinone having an x-ray powder diffraction patter with specific d spacings useful for treating inflammation, inflammatory bowel disease, allergies, arthritis and hypoglycemia utilizing the novel physical form as well as pharmaceutical compositions containing the same. A process for preparing Form II Tazofelone is described.
摘要翻译: PCT No.PCT / US96 / 14132 Sec。 371日期:1998年2月25日 102(e)1998年2月25日PCT PCT 1996年9月3日PCT公布。 第WO97 / 09320号公报 日期1997年3月13日本发明提供具有x射线的(+/-) - 5 - {[3,5-双(1,1-二甲基乙基)-4-羟基苯基]甲基} -4-噻唑烷酮的新型结晶形式II 具有用于治疗炎症,炎性肠病,过敏,关节炎和使用新型物理形式的低血糖的特定d间隔的粉末衍射图案以及含有该物质的药物组合物。 描述了制备II型Tazofelone的方法。
-
公开(公告)号:US5412094A
公开(公告)日:1995-05-02
申请号:US84651
申请日:1993-06-28
IPC分类号: C07D471/04 , A61K31/545 , C07D463/00 , C07D463/16 , C07D501/00 , C07D501/12 , C07D501/16 , C07D501/20 , C07D501/22 , C07D501/59 , C07D505/00 , C07D505/16 , C07D505/18
CPC分类号: C07D505/00 , C07D463/22 , C07D501/00
摘要: The invention provides complexes of the formula: ##STR1## wherein X is chloro, hydrogen, vinyl, or --CH.sub.3,Z is O;is 0-5;Y is phenyl or 1,4-cyclohexadien-1-yl;R.sub.1 and R.sub.2 are hydrogen or hydroxy, with the proviso that R.sub.1 and R.sub.2 are not both hydrogen andR.sub.3 is --COO.sup.-, --COO(C.sub.1 -C.sub.4 alkyl), --NO.sub.2 or ##STR2## wherein R.sub.4 is C.sub.1 -C.sub.4 alkyl.
摘要翻译: 本发明提供式:yl或-CH 3的复合物,Z是O; 是0-5; Y是苯基或1,4-环己二烯-1-基; R1和R2是氢或羟基,条件是R1和R2不同时为氢,R3为-COO-,-COO(C1-C4烷基),-NO2或
-
3.
公开(公告)号:US6001996A
公开(公告)日:1999-12-14
申请号:US439540
申请日:1995-05-11
IPC分类号: C07D463/00 , C07D463/16 , C07D501/00
CPC分类号: C07D501/00 , C07D463/22
摘要: The invention provides complexes of the formula: ##STR1## wherein X is chloro, hydrogen, vinyl, or --CH.sub.3,Z is CH.sub.2 or S;n is 0-5;Y is phenyl or 1,4-cyclohexadien-1-yl;R.sub.1 and R.sub.2 are hydrogen or hydroxy, with the proviso that R.sub.1 and R.sub.2 are not both hydrogen andR.sub.3 is --COO.sup.-, --COO(C.sub.1 -C.sub.4 alkyl), --NO.sub.2 or ##STR2## wherein R.sub.4 is C.sub.1 -C.sub.4 alkyl.
摘要翻译: 本发明提供下式的配合物:其中X是氯,氢,乙烯基或-CH 3,Z是CH 2或S; n为0-5; Y是苯基或1,4-环己二烯-1-基; R1和R2是氢或羟基,条件是R1和R2不同时为氢,R3为-COO-,-COO(C1-C4烷基),-NO2或其中R4为C1-C4烷基。
-
-